| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18555 R78889 |
Okubo (Controls unexposed, general population), 2025 | Attention-deficit hyperactivity disorder (ADHD) - ICD-10 codes (F90 - diagnoses only or ADHD's medications) - Mean follow up 4.4 years | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: prescription or medical files | 1.22 [1.06;1.41] | -/42,123 -/42,123 | - | 42,123 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18556 R78896 |
Okubo (Controls unexposed, sibling), 2025 | Attention-deficit hyperactivity disorder (ADHD) - ICD-10 codes (diagnoses only or ADHD's medications) - Mean follow up 4.4 years | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | sibling excluded | Adjustment: Yes Control group: Sibling Paracetamol use: prescription or medical files |
0.86 [0.52;1.44] excluded (control group) |
-/11,696 -/11,897 | - | 11,696 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18664 R79317 |
Pleau, 2025 | Attention-deficit/hyperactivity disorder (ADHD) - (1) at least two dates with a diagnostic code of ADHD ; (2) at least two dates with a filled prescription for an ADHD medication or (3) at least one diagnosis of ADHD and one filled prescription for an ADHD medication - At least 2 years | 2nd and/or 3rd trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: prescription or medical files | 1.09 [0.94;1.27] | 208/1,827 12,788/176,993 | 12,996 | 1,827 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S16629 R69722 |
Ahlqvist (Population-Based), 2024 | Attention-deficit/hyperactivity disorder (ADHD) - ICD-10 (F90) or ICD-9 (314) - Median (IQR) follow-up of 13.4 (7.6-19.8) years | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 1.07 [1.05;1.10] | 12,834/185,909 133,552/2,294,888 | 146,386 | 185,909 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S16630 R69728 |
Ahlqvist (Sibling), 2024 | Attention-deficit/hyperactivity disorder (ADHD) - ICD-10 (F90) or ICD-9 (314) - Median (IQR) follow-up of 13.4 (7.6-19.8) years | during pregnancy (anytime or not specified) | population based cohort retrospective | sibling excluded | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy |
0.98 [0.94;1.02] excluded (control group) |
8,526/- 87,679/- | 96,205 | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S16639 R69757 |
Chen, 2019 | Diagnoses of ADHD (ICD-9-CM code: 314) by board-certified psychiatrists on the basis of diagnostic interviews and clinical judgement - Age 0 - 15 years old (mean diagnosis 3.71) | during pregnancy (anytime or not specified) | nested case control | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: prescription or medical files | 1.20 [1.01;1.42] | 676/3,236 274/1,514 | 950 | 3,236 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S16655 R69967 |
Ystrom or Gustavson (Gustavson 2021 - Sibling), 2017 | Attention deficit hyperactivity disorder - ICD-10 code F90 - Between 0 and 18 years old (Exposed >28 days) | during pregnancy (anytime or not specified) | prospective cohort | sibling excluded | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy |
2.02 [1.17;3.25] excluded (control group) |
-/469 -/12,080 | - | 469 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S16651 R69922 |
Ystrom or Gustavson (Ystrom - Population-Based), 2017 | Attention-deficit/hyperactivity (ADHD - diagnosis of hyperkinetic disorder (F90.0, F90.1, F90.8, or F90.9)) - At 3-15 years old. | during pregnancy (anytime or not specified) | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 1.12 [1.02;1.24] | -/52,707 -/60,266 | - | 52,707 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S16641 R69813 |
Liew, 2014 | Hyperkinetic disorder diagnosis (ICD-10: F90.0-F90.9) - Mean age of children at the end of follow-up: 10.7 years (range, 8.2-13.4 years) | during pregnancy (anytime or not specified) | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 1.37 [1.19;1.59] | 551/36,187 283/28,135 | 834 | 36,187 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 6 studies | 1.16 [1.07;1.25] | 161,166 | 321,989 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, general population; 2: Population-Based; 3: Ystrom - Population-Based;
Asymetry test p-value = 0.0497 (by Egger's regression)
slope=0.0454 (0.0180); intercept=1.8502 (0.6649); t=2.7826; p=0.0497
excluded 16655, 16630, 18556